Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 Prominent Growth Companies With Strong Insider Ownership

In This Article:

As global markets continue to navigate political developments and economic shifts, U.S. stocks have been buoyed by optimism surrounding trade policies and advancements in artificial intelligence, with major indices reaching new highs. In this environment, growth stocks have outpaced their value counterparts, capturing the attention of investors looking for robust opportunities. A key characteristic of a promising stock in such conditions is strong insider ownership, which often signals confidence from those closest to the company's operations and strategy.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)

17.3%

20.5%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Laopu Gold (SEHK:6181)

36.4%

36.6%

Pharma Mar (BME:PHM)

11.9%

55.1%

Kingstone Companies (NasdaqCM:KINS)

20.8%

24.9%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

135%

Elliptic Laboratories (OB:ELABS)

26.8%

121.1%

Fulin Precision (SZSE:300432)

13.6%

71%

HANA Micron (KOSDAQ:A067310)

18.2%

119.4%

Findi (ASX:FND)

35.8%

110.7%

Click here to see the full list of 1482 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Scandi Standard

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Scandi Standard AB (publ) is engaged in the production and sale of chilled, frozen, and ready-to-eat chicken products across Sweden, Norway, Ireland, Denmark, Finland, Germany, the United Kingdom, rest of Europe and internationally with a market cap of SEK5.45 billion.

Operations: The company's revenue is derived from its Ready-To-Cook segment, which generated SEK9.80 billion, and its Ready-To-Eat segment, contributing SEK2.56 billion.

Insider Ownership: 14.9%

Earnings Growth Forecast: 20.7% p.a.

Scandi Standard's earnings are forecast to grow significantly at 20.7% annually, outpacing the Swedish market average. Revenue growth is also expected to surpass the market, albeit at a slower rate of 5.4%. Despite an unstable dividend track record and high debt levels, insider confidence is evident with substantial buying activity and no significant selling in recent months. The stock trades at 51.3% below estimated fair value but shows low future Return on Equity projections.

OM:SCST Earnings and Revenue Growth as at Jan 2025
OM:SCST Earnings and Revenue Growth as at Jan 2025

Suzhou Zelgen BiopharmaceuticalsLtd

Simply Wall St Growth Rating: ★★★★★☆